Seismic Therapeutic
Urjana Poreci, MBA is a Senior Program Manager at Seismic Therapeutic. Previously, Urjana worked as a Program Manager at Pandion Therapeutics and Alnylam Pharmaceuticals. Urjana has experience in bioanalytical science, biomarker development, and project management in the pharmaceutical industry. Urjana also holds a Master of Business Administration from Questrom School of Business, Boston University, and a Bachelor of Science in Biochemistry from Suffolk University.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.